Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects

被引:0
作者
Toshio Fujioka
Aoi Yoshiiwa
Tadayoshi Okimoto
Masaaki Kodama
Kazunari Murakami
机构
[1] Oita University Faculty of Medicine,Department of Gastroenterology and Division of Digestive Endoscopy
来源
Journal of Gastroenterology | 2007年 / 42卷
关键词
guideline; management; treatment; resistance;
D O I
暂无
中图分类号
学科分类号
摘要
In the years that followed the issuance in 2000 of the Guidelines for the Management of Helicobacter pylori Infection in Japan by the Japanese Society for Helicobacter Research (JSHR), a number of major issues arose, including the emergence of H. pylori strains resistant to clarithromycin as part of primary eradication therapy, and this led to the Guidelines being revised by the JSHR in 2003. While the JSHR aimed in the 2000 Guidelines to prepare clinicians for the task ahead in view of H. pylori eradication therapy becoming available, the JSHR went a step further in the 2003 Guidelines to include more evidence-based recommendations to address clinical and institutional challenges and issues of interest in the management of H. pylori infection in Japan. Thus, a number of diseases were upgraded to either class A or B indications for H. pylori eradication, including mucosa-associated lymphoid tissue lymphoma (class A), and after endoscopic mucosal resection for early gastric cancer, atrophic gastritis, and gastric hyperplastic polyp (all class B), with further diseases such as extragastric disease also included as class C indications requiring further examination. Concern was expressed over reliance on a single diagnostic test for H. pylori infection, which is in place due to institutional constraints. Metronidazole was also recommended for use in the place of clarithromycin as part of a second-line eradication regimen in light of increasing clarithromycin resistance, although metronidazole remains to be approved for health insurance coverage. Finally, areas requiring further clinical research and endeavors, including establishment of second-line eradication therapy, were also proposed in the 2003 Guidelines to point the way for the future.
引用
收藏
页码:3 / 6
页数:3
相关论文
共 50 条
[41]   Multidrug resistance in Helicobacter pylori: current state and future directions [J].
Boyanova, Lyudmila ;
Hadzhiyski, Petyo ;
Kandilarov, Nayden ;
Markovska, Rumyana ;
Mitov, Ivan .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (09) :909-915
[42]   Current Status of the Third-Line Helicobacter pylori Eradication [J].
Choi, Jae Ho ;
Yang, Young Joo ;
Bang, Chang Seok ;
Lee, Jae Jun ;
Baik, Gwang Ho .
GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
[43]   Quality appraisal of clinical guidelines for Helicobacter pylori infection and systematic analysis of the level of evidence for recommendations [J].
Ou, Jiayin ;
Li, Jiayu ;
Liu, Yang ;
Su, Xiaohong ;
Li, Wanchun ;
Zheng, Xiaojun ;
Zhang, Lang ;
Chen, Jing ;
Pan, Huafeng .
PLOS ONE, 2024, 19 (04)
[44]   Management of Helicobacter pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010-2019 [J].
Arino Perez, Ines ;
Martinez-Dominguez, Samuel J. ;
Alfaro Almajano, Enrique ;
Carrera-Lasfuentes, Patricia ;
Lanas, Angel .
ANTIBIOTICS-BASEL, 2022, 11 (05)
[45]   Epidemiology, pathogenicity, risk factors, and management of Helicobacter pylori infection in Saudi Arabia [J].
Ibrahim, Mutasim E. .
BIOMOLECULES AND BIOMEDICINE, 2024, 24 (03) :440-453
[46]   Management of Helicobacter pylori Infection: What Should the Surgeon Know? [J].
Selgrad, Michael ;
Malfertheiner, Peter .
VISCERAL MEDICINE, 2017, 33 (03) :216-219
[47]   Ocular onchocerciasis: current management and future prospects [J].
Babalola, Olufemi Emmanuel .
CLINICAL OPHTHALMOLOGY, 2011, 5 :1479-1491
[48]   Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020 [J].
Jung, Hye-Kyung ;
Kang, Seung Joo ;
Lee, Yong Chan ;
Yang, Hyo-Joon ;
Park, Seon-Young ;
Shin, Cheol Min ;
Kim, Sung Eun ;
Lim, Hyun Chul ;
Kim, Jie-Hyun ;
Nam, Su Youn ;
Shin, Woon Geon ;
Park, Jae Myung ;
Choi, Il Ju ;
Kim, Jae Gyu ;
Choi, Miyoung .
GUT AND LIVER, 2021, 15 (02) :168-195
[49]   Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection [J].
Dargenio, Costantino ;
Dargenio, Vanessa Nadia ;
Bizzoco, Francesca ;
Indrio, Flavia ;
Francavilla, Ruggiero ;
Cristofori, Fernanda .
MEDICINA-LITHUANIA, 2021, 57 (07)
[50]   Current status and future prospects for the treatment of antiphospholipid syndrome [J].
Al Marzooqi, Ahlam ;
Leone, Alessia ;
Al Saleh, Jamal ;
Khamashta, Munther .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (09) :927-935